RE: LFT to Market24 Feb 2021 19:25
Is anyone else confused by the Mologic agreement/relationship with us?
-We’re told they’ve been collaborating for months - anyone know why?
-It seems they’re useful to us now because of their ISO accreditation which can accelerate CE and therefore commercialisation. But if that’s so, why didn’t we ask BBI to get the CE mark instead of a “competitor”? Perhaps they’re not a competitor??
-Mologic said in December that wider validation results for their test were expected to be available during Jan, but if they were, they weren’t published ( from what Ben says it seems they might get published next week). This “delay” coupled with the somewhat strange agreement to help us in between times seems a bit weird to me.
-Worth noting that the tech transfer to ODX of the Mologic test remains ongoing, and that until this week neither Mologic or AVCT had made any comment about either test going through PD, which again seems odd given that both companies were involved in “moonshot” from the outset after meeting BJ in August, and their apparent status domestically.
And then there was the ODX guy who, post the Mologic CE announcement, let slip he was working on the AVCT test...? Why would he be doing that...?
I just can’t square the circle in my own mind and do wonder whether there’s more collaboration going on behind the scenes between us, Mologic, ODX and perhaps others than we know. Might we get some kind of wider “collaborative”announcement about domestic supply of tests ready for 8th March to satisfy what moonshot was all about in the first place, ie bringing U.K. diagnostics together to drive a desired sovereign outcome?
This is probably all ****** and if so, please ignore!!!